• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Blood Donation

Frequent Platelet Donation and Risk for T-cell Lymphopenia

In the United States, over 90% of platelets are collected by plateletpheresis, and donors may give platelets up to 24…

November 22, 2023

Lymphopenia from Plateletpheresis does not Affect Immune Response

Leukoreduction during plateletpheresis is routinely performed to prevent alloimmunization and febrile reactions when platelets are transfused.  In 1988, the U.S….

August 2, 2023

Frequent Whole Blood Donations Not Associated with Cardiovascular Disease

Few studies have examined the effects on whole blood (WB) donations on cardiovascular health.  Researchers associated with the Australian Red…

May 17, 2023

Individual Risk Assessment Questions for Potential Donors at Higher Risk for HIV

In January 2023, the U.S. FDA issued draft guidance recommending individual risk-based assessments for potential donors at higher risk for…

April 26, 2023

Randomized Trial Results on Donor Sex and RBC Recipient Mortality

Observational studies and systematic reviews have found conflicting results on the association between RBC donor sex and associated transfusion recipient…

April 18, 2023

Whole Blood Derived Platelet vs. Apheresis Platelets

During the COVID-19 pandemic, the U.S. experienced significant blood product shortages. In 2019, approximately 2.5 million platelet units were collected…

April 12, 2023

Individualized Behavior-Based MSM Donor Eligibility Would Increase Pool of Potential Donors

In order to reduce the risk of blood transfusion-associated HIV transmission during the window period between exposure and detectability among…

October 12, 2022

Iron Repletion Does Not Effect Donor Well-Being or Red Cell Quality

Iron deficiency develops in over one third of regular, repeat blood donors.  In order to exam the physiological consequences of…

September 28, 2022

Donor Deferral Recommendations for HIV Pre-exposure Prophylaxis

In December 2021, the U.S. FDA approved injectable cabotegravir (Apretude) as pre-exposure prophylaxis (PrEP) to prevent HIV transmission.  PrEP, post-exposure…

September 14, 2022

Are WHO Guidelines for Serum Ferritin Levels for Female Blood Donors Too Low?

The current World Health Organization (WHO) guidelines, based on expert opinion with low-grade evidence, define iron deficiency in healthy blood…

July 6, 2022

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 13
  • Go to Next Page »

Primary Sidebar

Latest News

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley